<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00640575</url>
  </required_header>
  <id_info>
    <org_study_id>sais-201204</org_study_id>
    <nct_id>NCT00640575</nct_id>
  </id_info>
  <brief_title>Subacromial Ultrasound-guided or Systemic Steroid Injection for Rotator Cuff Disease, a Randomized Double Blinded Study</brief_title>
  <official_title>Subacromial Ultrasound-guided or Systemic Steroid Injection for Rotator Cuff Disease, a Randomized Double Blinded Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ullevaal University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Oslo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Corticosteroid injections is a popular treatment option in shoulder disease. The evidence of
      effectiveness of corticosteroid injections is however contradicting. The importance of the
      accuracy of the steroid placement have been discussed and recently there are a few studies
      indicating better treatment effect if the injections are guided towards specific anatomical
      structures by real time ultrasound imaging. None of these studies have been double blinded.
      The aim of this study is to investigate the importance of placement of steroid injection in
      patients with rotator cuff disease by comparing systemic and ultrasound-guided injection in
      the subacromial bursa using a double blinded design.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2005</start_date>
  <completion_date type="Actual">December 2006</completion_date>
  <primary_completion_date type="Actual">October 2006</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Shoulder Pain and Disability Index (SPADI)</measure>
    <time_frame>2 and 6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Western Ontario Rotator Cuff Index (WORC)</measure>
    <time_frame>2 and 6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain in activity (7 point ordinal scale)</measure>
    <time_frame>2 and 6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain at rest (7 point ordinal scale)</measure>
    <time_frame>2 and 6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in main complaint (18 point ordinal scale)</measure>
    <time_frame>2 and 6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Active range of motion</measure>
    <time_frame>2 and 6 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">106</enrollment>
  <condition>Rotator Cuff Disease</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Local</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Systemic</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>triamcinolone and lidocaine hydrochloride</intervention_name>
    <description>Ultrasound-guided lidocaine hydrochloride 5 ml (10 mg/ml) injection in the subacromial bursa and a triamcinolone 2 ml (10 mg/ml) and 2 ml lidocaine hydrochloride (10 mg/ml) intramuscular injection in the gluteal region</description>
    <arm_group_label>B</arm_group_label>
    <other_name>Xyloacain (AstraZeneca)</other_name>
    <other_name>Kenakort-T (Bristol-Myers Squibb)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>triamcinolone and lidocaine hydrochloride</intervention_name>
    <description>Ultrasound-guided injection of 2 ml triamcinolone (10 mg/ml) and 5 ml lidocaine hydrochloride (10 mg/ml) in the subacromial bursa and 4 ml intramuscular injection of lidocaine hydrochloride in the gluteal region</description>
    <arm_group_label>A</arm_group_label>
    <other_name>Kenacort-T (Bristol-Myers Squibb)</other_name>
    <other_name>Xylocain (AstraZeneca)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  above 18 years

          -  shoulder pain for more than 3 months

          -  pain at abduction of the affected shoulder

          -  less than 50 % reduced passive glenohumeral range of motion in no more than one
             direction of either abduction, external or internal rotation

          -  2 of 3 positive isometric test of external rotation, internal rotation and abduction

          -  positive Hawkins-Kennedy impingement test

        Exclusion Criteria:

          -  SPADI score below 30 points

          -  symptomatic acromioclavicular arthritis

          -  clinical and radiological findings indicating glenohumeral joint pathology

          -  referred pain from neck or internal organs

          -  clinical signs of a cervical syndrome

          -  generalized muscular pain syndrome with bilateral muscular pain in the neck and
             shoulders

          -  history of inflammatory arthritis

          -  diabetes mellitus type 1

          -  contraindications to local steroid or lidocaine hydrochloride injections

          -  corticosteroid injections last month before inclusion

          -  unable to respond to questionnaires
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ole M Ekeberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Oslo</affiliation>
  </overall_official>
  <verification_date>March 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 9, 2008</study_first_submitted>
  <study_first_submitted_qc>March 16, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 21, 2008</study_first_posted>
  <last_update_submitted>July 3, 2011</last_update_submitted>
  <last_update_submitted_qc>July 3, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 6, 2011</last_update_posted>
  <responsible_party>
    <name_title>Ole Marius Ekeberg</name_title>
    <organization>University of Oslo</organization>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Triamcinolone hexacetonide</mesh_term>
    <mesh_term>Triamcinolone</mesh_term>
    <mesh_term>Triamcinolone Acetonide</mesh_term>
    <mesh_term>Triamcinolone diacetate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

